CFR Still with Top Bid for South African
South African drug maker Adcock Ingram has received additional unsolicited bids from potential buyers, it says, but none yet bigger than a $1.3bn...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.